Search by Drug Name or NDC
NDC 53002-1718-01 Priftin 150 mg/1 Details
Priftin 150 mg/1
Priftin is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RPK Pharmaceuticals, Inc.. The primary component is RIFAPENTINE.
MedlinePlus Drug Summary
Rifapentine is used with other medications to treat active tuberculosis (TB; a serious infection that affects the lungs and sometimes other parts of the body) in adults and children 12 years of age and older. Rifapentine is also used with isoniazid (Laniazid) to treat adults and children 2 years of age and older with latent (resting or nongrowing) TB, including those in close contact with people who have active TB, a positive tuberculin skin test, human immunodeficiency virus (HIV), or those with pulmonary fibrosis (scarring of the lungs with an unknown cause). Rifapentine is in a class of medications called antimycobacterials. It works by killing the bacteria that cause infection. Antibiotics such as rifapentine will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 53002-1718-01Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Rifapentine
Product Information
| NDC | 53002-1718 |
|---|---|
| Product ID | 53002-1718_8b10a036-c487-4ec7-a7bf-460bce7d2bd7 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Priftin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | rifapentine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 150 |
| Active Ingredient Units | mg/1 |
| Substance Name | RIFAPENTINE |
| Labeler Name | RPK Pharmaceuticals, Inc. |
| Pharmaceutical Class | Rifamycin Antimycobacterial [EPC], Rifamycins [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021024 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 53002-1718-01 (53002171801)
| NDC Package Code | 53002-1718-1 |
|---|---|
| Billing NDC | 53002171801 |
| Package | 3 BLISTER PACK in 1 CARTON (53002-1718-1) / 8 TABLET, FILM COATED in 1 BLISTER PACK |
| Marketing Start Date | 2022-01-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |